BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9048399)

  • 21. Prophylaxis against venous thromboembolism after surgery for cancer.
    Moulias S; Bouchon JP; Meaume S
    N Engl J Med; 2002 Jul; 347(3):220; author reply 220. PubMed ID: 12124417
    [No Abstract]   [Full Text] [Related]  

  • 22. [Thrombosis prophylaxis in knee arthroscopy. A survey of a Cochrane review].
    Jørgensen LN; Lykke J
    Ugeskr Laeger; 2008 Nov; 170(45):3646-9. PubMed ID: 18986613
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prevention of postoperative venous thromboembolic complications].
    Savel'ev VS; Gologorskiĭ VA; Kirienko AI; Gel'fand BR
    Anesteziol Reanimatol; 2000; (4):68-71. PubMed ID: 11014003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-molecular-weight heparin for initial treatment of venous thromboembolism.
    Brewer D
    Am Fam Physician; 2005 Jul; 72(1):75-6. PubMed ID: 16035683
    [No Abstract]   [Full Text] [Related]  

  • 25. The optimal long-term treatment of venous thromboembolism.
    Prandoni P
    Clin Adv Hematol Oncol; 2004 Nov; 2(11):729-32. PubMed ID: 16170889
    [No Abstract]   [Full Text] [Related]  

  • 26. Can we use a low molecular weight heparin after mechanical prosthetic heart valve surgery?
    Meurin P; Tabet JY
    Heart; 2008 Feb; 94(2):131-2. PubMed ID: 18195116
    [No Abstract]   [Full Text] [Related]  

  • 27. Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis.
    Couturaud F; Julian JA; Kearon C
    Thromb Haemost; 2001 Oct; 86(4):980-4. PubMed ID: 11686355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent thromboembolism in ovarian cancer.
    Fuglsang J; Ingerslev J; Havsteen H
    Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1218-20. PubMed ID: 15548160
    [No Abstract]   [Full Text] [Related]  

  • 29. [The risk of venous thromboembolism during air travel].
    Sanchez O
    Rev Prat; 2007 Apr; 57(7):721-3. PubMed ID: 17654820
    [No Abstract]   [Full Text] [Related]  

  • 30. Deep vein thromboembolism in malignant diseases.
    Zemková M; Meyboom RH; Blazek M; Kotlárová J; Vlcek J; Jebavý L
    Ceska Slov Farm; 2007 Jan; 56(1):5-10. PubMed ID: 17432275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
    Ruiz Manzano J; Monreal M
    Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434
    [No Abstract]   [Full Text] [Related]  

  • 33. Low molecular weight heparins: prophylaxis of venous thromboembolism in surgical patients.
    Kakkar VV
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):9-19. PubMed ID: 9399405
    [No Abstract]   [Full Text] [Related]  

  • 34. Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism.
    Johnston JA; Brill-Edwards P; Ginsberg JS; Pauker SG; Eckman MH
    Am J Med; 2005 May; 118(5):503-14. PubMed ID: 15866253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticoagulants and cancer survival.
    Piccioli A; Falanga A; Prandoni P
    Semin Thromb Hemost; 2006 Nov; 32(8):810-3. PubMed ID: 17171594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent clinical trials in the treatment of venous thromboembolism and unstable angina with low molecular weight heparins.
    Hirsh J
    Curr Opin Hematol; 1998 Sep; 5(5):360-5. PubMed ID: 9776217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is there enough evidence that low-molecular-weight heparin is superior to unfractionated heparin in pulmonary embolism?
    Sharma GK
    Arch Intern Med; 2000 Jul; 160(13):2065-6. PubMed ID: 10888989
    [No Abstract]   [Full Text] [Related]  

  • 38. Current and potential uses of low molecular weight heparin: a review and an economic analysis.
    Seo P; Locke CF
    Am J Manag Care; 2000 Apr; 6(4):498-506; quiz 507-8. PubMed ID: 10977456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients].
    Zabolotskikh IB; Sin'kov SV; Klevko VA
    Anesteziol Reanimatol; 2001; (2):70-5. PubMed ID: 11494909
    [No Abstract]   [Full Text] [Related]  

  • 40. [Low molecular weight heparins].
    Taurand S
    Soins; 1990 Dec; (543):I-II. PubMed ID: 1965350
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.